Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H11NO4S |
| Molecular Weight | 205.232 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)N1CSC[C@H]1C(O)=O
InChI
InChIKey=XBJWOGLKABXFJE-YFKPBYRVSA-N
InChI=1S/C7H11NO4S/c1-2-12-7(11)8-4-13-3-5(8)6(9)10/h5H,2-4H2,1H3,(H,9,10)/t5-/m0/s1
| Molecular Formula | C7H11NO4S |
| Molecular Weight | 205.232 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Telmesteine, a mucoactive agent with strong anti-inflammatory properties. Telmesteine was used in the treatment of respiratory tract disorders. This compound inhibits elastase and collagenase and may be useful in the treatment of skin aging and psoriasis. The anti-inflammatory properties of telmesteine are mediated by blocking PI3K/Akt/IKK activities. Thus, telmesteine can be used as a potent anti-inflammatory agent for skin inflammatory and anti-inflammatory materials in cosmetics,
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:01 GMT 2025
by
admin
on
Mon Mar 31 18:33:01 GMT 2025
|
| Record UNII |
124I3FE35T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C74536
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C091508
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
C74550
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
124I3FE35T
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
6573
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
100000082462
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
85929
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | RxNorm | ||
|
122946-43-4
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
SUB10873MIG
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
DTXSID60153804
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
2582
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
65946
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107621
Created by
admin on Mon Mar 31 18:33:01 GMT 2025 , Edited by admin on Mon Mar 31 18:33:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
